Injection delivery system developer ApiJect announced today that it completed a private investment round worth $111 million.
Royalty Pharma and Jefferies Financial Group led the investment round. Jefferies also acquired a revenue interest in addition to equity through the financing.
Get the full story at our sister site, Drug Delivery Business News.